Page 784 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 784
CHaPtEr 55 Scleroderma–Systemic Sclerosis 755
the-scleroderma-lung-study-ii-sls-ii-shows-that-bothoral-cyclophospha 29. Denton CP, Lapadula G, Mouthon L, et al. Renal complications and
mide-cyc-and-mycophenolate-mofitil-mmf-are-efficacious-in-treatingpro scleroderma renal crisis. Rheumatology (Oxford) 2009;48(Suppl.iii):32–5.
gressive-interstitial-lung-disease-ild-in-patients-w/. 30. Haythornthwaite JA, Heinberg LJ, McGuire L. Psychologic factors in
23. Silver KC, Silver RM. Management of systemic-sclerosis-associated scleroderma. Rheum Dis Clin North Am 2003;29:427–39.
interstitial lung disease. Rheum Dis Clin North Am 2015;41:439–57. 31. Khanna D, Denton CP. Evidence-based management of rapidly
24. Lota HK, Wells AU. The evolving pharmacotherapy of pulmonary progressing systemic sclerosis. Best Pract Res Clin Rheum
fibrosis. Expert Opin Pharmacother 2013;14:79–89. 2010;24:387–400.
25. Le Pavec JL, Humbert M, Mouthon L, et al. Systemic sclerosis-associated 32. Denton CP. Advances in pathogenesis and treatment of systemic sclerosis.
pulmonary arterial hypertension. Am J Respir Crit Care Med Clin Med (Lond) 2016;16:55–60.
2010;181:1285–93. 33. Van Laar JM, Naraghi K, Tyndall A. Haematopoietic stem cell
26. Mathai SC, Hassoun PM. Therapy for pulmonary arterial hypertension transplantation for poor-prognosis systemic sclerosis. Rheumatology
associated with systemic sclerosis. Curr Opin Rheumatol 2009;21: (Oxford) 2015;54:2126–33.
642–8. 34. Boin F, Hummers LK. Scleroderma-like fibrosing disorders. Rheum Dis
27. Humbert M, Yaici A, de Groote P, et al. Screening for pulmonary arterial Clin North Am 2008;34:199–220.
hypertension in patients with systemic sclerosis: clinical characteristics at 35. Todd DJ, Kay J. Gadolinium-induced fibrosis. Annu Rev Med
diagnosis and long-term survival. Arthritis Rheum 2011;63:3522–30. 2016;67:273–91.
28. Follansbee WP, Zerbe TR, Medsger TA Jr. Cardiac and skeletal muscle 36. Allen J, Peterson A, Sufit R, et al. Post-epidemic eosinophilia myalgia
disease in systemic sclerosis (scleroderma): a high risk association. Am syndrome associated with L-tryptophan. Arthritis Rheum
Heart J 1993;125:194–203. 2011;63:3633–9.
